scispace - formally typeset
T

Takeaki Hashimoto

Researcher at Fukushima Medical University

Publications -  5
Citations -  151

Takeaki Hashimoto is an academic researcher from Fukushima Medical University. The author has contributed to research in topics: Fatty acid synthase & Internal medicine. The author has an hindex of 4, co-authored 4 publications receiving 134 citations.

Papers
More filters
Journal ArticleDOI

Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers

TL;DR: Evidence is suggested that an invasion-independent metastatic pathway is possible in a wide variety of human cancers and further investigation of this phenomenon may present new therapeutic strategies for the amelioration of cancer metastasis.
Journal ArticleDOI

Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis.

TL;DR: A subset of human gastric carcinoma expresses H-FABP and its expression is associated with FAS status, disease progression, tumor aggressiveness and poor patient survival.
Journal ArticleDOI

Liver-Type Fatty Acid-Binding Protein Is Highly Expressed in Intestinal Metaplasia and in a Subset of Carcinomas of the Stomach without Association with the Fatty Acid Synthase Status in the Carcinoma

TL;DR: L-FABP is highly and intensely expressed in metaplasia and in a subset of gastric adenocarcinomas, without association with progression, prognosis and fatty acid synthase status of the carcinoma.
Journal ArticleDOI

Multiple epithelial cysts of the spleen and on the splenic capsule, and high serum levels of CA19-9, CA125 and soluble IL-2 receptor.

TL;DR: It is suspected that the splenic cysts were derived from the capsular lining cells that showed migration from the capsule or formed microcysts on thesplenic capsule, as in the case of ovarian inclusion cysts.
Journal ArticleDOI

A Hepatitis B Virus Reactivation Case Potentially Triggered by the Onset of Diffuse Large B Cell Lymphoma

TL;DR: An 81-year-old man who underwent rituximab-containing chemotherapy for chronic lymphocytic leukemia (CLL) was diagnosed with hepatitis B virus (HBV) reactivation, and developed diffuse large B cell lymphoma (DLBCL) after improvement in his hepatitis.